Where To Inject NAD
Luo D, Chen M, Li Q, et al
In this study, CP administration led to a significant decrease in SOD, CAT, and GPx activity, indicating pronounced oxidative stress, which aligns with findings from previous studies (30, 35)
Primary peptides: KPV at 300 to 500 mcg subcutaneously daily (mast cell stabilization) BPC-157 at 250 mcg subcutaneously twice daily (tissue repair, additional mast cell stabilization) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune regulation) Implementation schedule: Week 1: Start KPV alone at lower dose (200 mcg) to assess tolerance Week 2: Add BPC-157 at 200 mcg twice daily
GLP-1 is a hormone released by cells in the gut after eating
Based on these findings, a diagnosis of nAMD was made by ophthalmologists in our hospital, and anti-vascular endothelial growth factor (VEGF) therapy with aflibercept intravitreal injection for the left eye was started 3 weeks later